Data by Data Type

All |

2 | 3 | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y | Z | [

Guinea Malaria Indicator Survey 2021

République de Guinée Enquête sur les Indicateurs du Paludisme et de l’Anémie en Guinée (EIPAG) 2021

Cross-sectional - GPS coordinates (GIS) - Household - Individual - Nationally representative - Subnationally representative - Urban-rural representative

GHDx Entry last modified on: Oct 3, 2022

Premise Malaria COVID-19 Health Services Disruption Survey 2021

Cross-sectional - Individual

GHDx Entry last modified on: Dec 12, 2022

Premise Women's Health COVID-19 Health Services Disruption Survey 2021

Cross-sectional - Individual

GHDx Entry last modified on: Dec 12, 2022

Premise Child Health COVID-19 Health Services Disruption Survey 2021

Cross-sectional - Individual

GHDx Entry last modified on: Dec 12, 2022

Premise Education COVID-19 Health Services Disruption Survey 2021

Cross-sectional - Individual

GHDx Entry last modified on: Dec 12, 2022

Premise General Population COVID-19 Health Services Disruption Survey 2021

Cross-sectional - Individual

GHDx Entry last modified on: Dec 12, 2022

Premise Infant and Maternal Health COVID-19 Health Services Disruption Survey 2021

Cross-sectional - Individual

GHDx Entry last modified on: Dec 12, 2022

Andhra Pradesh: '59% found to have Covid antibodies in sero-survey'

Epi surveillance

GHDx Entry last modified on: Aug 1, 2022

Presence of antibodies to SARS-CoV-2 in Sweden, 26 April - 9 May 2021

Förekomsten av antikroppar mot SARS-CoV-2 i Sverige, 26 april – 9 maj 2021

Epi surveillance

GHDx Entry last modified on: Aug 2, 2022

Madagascar Demographic and Health Survey 2021

Enquête Démographique et de Santé (EDSMD-V)

GPS coordinates (GIS) - Household - Individual - Interview - Nationally representative - Verbal autopsy

GHDx Entry last modified on: Aug 31, 2022

Brazil - Sergipe Evolution of the Prevalence of SARS-CoV-2 Infection 2021, Third Phase

Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Terceira Fase: 18 de fevereiro a 30 de março de 2021.

Epi surveillance

GHDx Entry last modified on: Jul 13, 2022

Jharkhand: 45% of population in 10 districts positive before 2nd wave: Sero survey

Epi surveillance

GHDx Entry last modified on: Aug 2, 2022

Portugal National Serological Survey COVID-19 (2nd phase) 2021

Inquérito Serológico Nacional COVID-19 (2.ª fase) (INS COVID-19)

Individual

GHDx Entry last modified on: Nov 3, 2022

Seropositivity highest in Madhya Pradesh, lowest in Kerala, finds ICMR's national sero-survey

Epi surveillance

GHDx Entry last modified on: Aug 1, 2022

Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 5 (SoroEpi MSP)

Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 5

GHDx Entry last modified on: Oct 27, 2022

Senegal Malaria Indicator Survey 2020-2021

Enquête des Indicateurs du Paludisme au Sénégal 2020-2021 (EIPS 2020-2021)

Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative

GHDx Entry last modified on: Feb 8, 2023

Vietnam Multiple Indicator Cluster Survey 2020-2021

Survey Measuring Viet Nam Sustainable Development Goal Indicators On Children And Women 2020-2021

Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative

GHDx Entry last modified on: Feb 10, 2023

Kenya Malaria Indicator Survey 2020

Cross-sectional - GPS coordinates (GIS) - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative

GHDx Entry last modified on: Jan 28, 2022

Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020

Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER)

Epi surveillance

GHDx Entry last modified on: May 12, 2022

33.98% of Tripura has COVID-19 antibody in them, shows sero survey

Epi surveillance

GHDx Entry last modified on: May 12, 2022

Australia Household Impacts of Covid-19 Survey November 2020

Longitudinal

GHDx Entry last modified on: Jan 25, 2023

Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 4 (SoroEpi MSP)

Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4

GHDx Entry last modified on: Oct 27, 2022

Brazil - Maranhão Prevalence of SARS-CoV-2 Virus Infection Survey 2020 Phase II

Prevalência de infecção pelo vírus SARS-CoV-2 no Maranhão, segunda fase

Individual - Interview

GHDx Entry last modified on: Oct 21, 2022

Nepal National Sero-Prevalence Survey for COVID-19 2020 Round 1

ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION

GHDx Entry last modified on: May 12, 2022

India - Haryana Covid-19 Sero Survey Round 2, October 2020

Sero-prevalence of Anti-SARS-CoV-2 IgG antibodies in Haryana, India: A Population based Cross-Sectional Study (2nd Round)

Cross-sectional - Epi surveillance - Urban-rural representative

GHDx Entry last modified on: May 12, 2022

Burkina Faso National Nutrition Survey 2020

Enquête Nutritionnelle Nationale 2020; SMART 2020

Cross-sectional - Household - Individual - Interview

GHDx Entry last modified on: May 17, 2022

C''garh: 5.5 pc people have COVID-19 antibodies, says sero survey

Cross-sectional - Epi surveillance - Individual

GHDx Entry last modified on: May 12, 2022

Andhra Pradesh Sero Survey Show Nearly 20% of State’s Population Exposed to Covid-19

Cross-sectional - Epi surveillance - Urban only

GHDx Entry last modified on: May 12, 2022

Kolkata: One in Four People Have Covid Antibodies

GHDx Entry last modified on: May 12, 2022

Sweden - Uppsala First Wave COVID-19 ICU Patient Cohort Admitted Mar-Aug 2020, 3-6 Month Follow-up Sept-Nov 2020

Health facility - Individual - Interview - Longitudinal

GHDx Entry last modified on: Jan 27, 2022

20% of Andhra Exposed to Covid, Sero-survey Finds, Exposure Highest Where Case Tally Lowest

Cross-sectional - Epi surveillance - Urban only

GHDx Entry last modified on: Aug 1, 2022

Mexico - Yucatán Under-5 Endline Household Survey 2020

Cross-sectional - Household - Individual - Interview

GHDx Entry last modified on: Mar 12, 2022

29.1% people in Delhi developed antibodies against COVID-19, finds latest sero-survey

GHDx Entry last modified on: Aug 1, 2022

Press Briefing: Sero Survey Delhi

Cross-sectional - Urban only

GHDx Entry last modified on: Feb 10, 2022

India - Haryana Covid -19 Sero Survey Round 1, August 2020

Sero-prevalence of anti-SARS-CoV-2 IgG antibodies in Haryana, India: a Population-Based Cross Sectional Study

Epi surveillance

GHDx Entry last modified on: May 12, 2022

Over 56% of Delhi has Covid-19 Antibodies: Health Minister Satyendar Jain on 5th Serosurvey

Urban only

GHDx Entry last modified on: Apr 8, 2022

United States - Washington Hospitalized or Ambulatory Adults with Respiratory Viral Infections 2020

HAARVI

Health facility - Longitudinal - Outpatient

GHDx Entry last modified on: Sep 28, 2022

About 10 million people have been infected with the Corona virus in Afghanistan

حدود ده ملیون تن در افغانستان به ویروس کرونا مبتلا شده اند

GHDx Entry last modified on: Jul 13, 2021

[Preliminary results of the National Health and Nutrition Survey COVID-19]

Communiqué 255: Resultados preliminares de la Encuesta Nacional de Salud y Nutrición COVID-19

Cross-sectional - Epi surveillance - Household - Individual - Nationally representative

GHDx Entry last modified on: May 12, 2022

Switzerland - Zurich COVID-19 Hospitalizations, Symptoms, Complications, Quality of Life, and Mental Wellbeing 2020-2021

Individual - Longitudinal

GHDx Entry last modified on: Nov 3, 2022

Assam's Sero-survey found 23.7 per cent Seroprevalence in the State

Epi surveillance

GHDx Entry last modified on: Aug 1, 2022

United States - Ohio Prevalence of Current and Past COVID-19 in Adults July 2020

Prevalence of Current and Past COVID-19 in Ohio Adults

Epi surveillance - Individual

GHDx Entry last modified on: May 12, 2022

ORB General Population COVID-19 Health Services Disruption Survey 2020

Cross-sectional - Individual - Nationally representative

GHDx Entry last modified on: Dec 12, 2022

Norway SARS-CoV-2 Seroprevalence Residual Sera Follow-up Survey July-September 2020

Seroprevalence of SARS-CoV-2 in the Norwegian population measured in residual sera collected in late summer 2020

Epi surveillance - Individual

GHDx Entry last modified on: May 12, 2022

GHDx Entry last modified on: Jul 26, 2021

Premise Infant and Maternal Health COVID-19 Health Services Disruption Survey 2020

Cross-sectional - Individual

GHDx Entry last modified on: Dec 12, 2022

Premise Women’s Health COVID-19 Health Services Disruption Survey 2020

Cross-sectional - Individual

GHDx Entry last modified on: Dec 12, 2022

Main menu

Data by Data Type

Pages